3.865 USD
-0.04 (-1.15%)
Last: Feb 9, 2026, 11:18 AM
ChartMill assigns a Buy % Consensus number of 81% to OBIO. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 13.7. This target is 254.39% above the current price.
- OBIO was analyzed by 14 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about OBIO.
- In the previous month the buy percentage consensus was at a similar level.
- OBIO was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-09 | Barclays | Maintains | Overweight -> Overweight |
| 2025-12-10 | TD Cowen | Initiate | Buy |
| 2025-11-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-11-12 | Barclays | Maintains | Overweight -> Overweight |
| 2025-09-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-20 | BTIG | Downgrade | Buy -> Neutral |
| 2025-08-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-07 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-05 | Barclays | Maintains | Overweight -> Overweight |
| 2025-04-22 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-04-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-04-01 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-20 | BTIG | Initiate | Buy |
| 2025-03-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-02 | Barclays | Initiate | Overweight |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-08-22 | HC Wainwright & Co. | Initiate | Buy |
| 2024-07-25 | B. Riley Securities | Initiate | Buy |
| 2024-06-12 | Chardan Capital | Reiterate | Buy -> Buy |
| 2024-03-28 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-01-19 | Jefferies | Initiate | Buy |
| 2023-08-11 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-08-09 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-05-15 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-02-24 | Piper Sandler | Initiate | Overweight |
| 2023-02-07 | Chardan Capital | Initiate | Buy |
ORCHESTRA BIOMED HOLDINGS IN / OBIO FAQ
What do analysts expect the price target to be for ORCHESTRA BIOMED HOLDINGS IN (OBIO)?
14 analysts have analysed OBIO and the average price target is 13.7 USD. This implies a price increase of 254.39% is expected in the next year compared to the current price of 3.865.
Can you provide the consensus rating for ORCHESTRA BIOMED HOLDINGS IN stock?
The consensus rating for ORCHESTRA BIOMED HOLDINGS IN (OBIO) is 81.4286 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for ORCHESTRA BIOMED HOLDINGS IN stock?
The number of analysts covering ORCHESTRA BIOMED HOLDINGS IN (OBIO) is 14.